The use of instrumented gait analysis for individually tailored interdisciplinary interventions in children with cerebral palsy: a randomised controlled trial protocol

Table 3 Summary of measures to be collected. All patient characteristics and outcomes to be collected at baseline, 26 weeks and at primary endpoint (52 weeks) are listed in the table

		Instrument	Baseline	26 weeks	Primary endpoint
Baseline data and classification of function
	Age (years)		x
	Ability to carry out self-initiated movements	GMFCS	x		x
	Functional mobility	FMS	x		x
	Height (cm)		x		x
	Leg length (cm)		x		x
Primary outcome measure: Gait
	Overall gait pathology	GDI	x		x
Secondary outcome measures
	Walking performance (metre)	1-min walk	x		x
	Functional mobility	PEDI	x	x	x
	Health-related quality of life	PedsQL	x	x	x
	Overall health, pain and participation	PODCI	x	x	x
Explorative outcome measures Walking performance, gait pathology, spatio-temporal parameters, and behaviour of health care providers
	Gait pathology	GVS	x		x
	Step length and time Stride length and cadence Time of single support for each leg and double support Walking speed	IGA	x		x
	Family-centred behaviour of health care providers	MPOC-20	x	x	x
Recommended and applied interventions
	Categories of recommended interventions		x
	Categories of applied interventions			x	x

Abbreviations: GMFCS Gross Motor Function Classification System, FMS Functional Mobility Scale, IGA Instrumented gait analysis, GDI Gait Deviation Index, 1-min walk 1 min Walk Test, PEDI Pediatric Evaluation of Disability Inventory, PedsQL Pediatric Quality of Life Inventory Cerebral Palsy Module^TM, PODCI Pediatric Outcome Data Collection Instrument, GVS Gait Variable Score, MPOC-20 Measure of Processes of Care, CPUP Cerebral Palsy follow-Up Program

ISSN: 1471-2431